Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation
Open Access
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (2), 320-327
- https://doi.org/10.1016/j.ymthe.2005.08.005
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Identification of an immunodominant H‐2Db‐restricted CTL epitope of human PSAThe Prostate, 2005
- Induction of PSA‐specific CTLs and anti‐tumor immunity by a genetic prostate cancer vaccineThe Prostate, 2004
- Enhancement of DNA vaccine potency in rhesus macaques by electroporationVaccine, 2004
- Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applicationsThe Journal of Gene Medicine, 2004
- Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivoNature Immunology, 2003
- Cross priming or direct priming: is that really the question?Current Opinion in Immunology, 2003
- Electroporation improves the efficacy of DNA vaccines in large animalsVaccine, 2002
- Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA VaccinesJournal of Virology, 2001
- Cutaneous Transfection and Immune Responses to Intradermal Nucleic Acid Vaccination Are Significantly Enhanced by in Vivo ElectropermeabilizationMolecular Therapy, 2001
- Induction of tumor antigen-specific immunity using plasmid DNA immunization in miceCancer Gene Therapy, 1999